Work

Prediction of response to treatment with infliximab (Remicade®) in a German prospective open-label multicenter trial in refractory Crohn's disease

Year: 2001

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(01)83089-4

Authors: T ANDUS, H HERFARTH, F OBERMEIER, T KUEHBACHER, S MASCHERETTI, W THRIENE, J SCHOELMERICH, S SCHREIBER

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2082910868

FWCI: 0.902

Cites:

Cited by: 11

Related to: 10